Jeffrey Niew, President and CEO of Knowles Corp (NYSE:KN), filed a Form 4 on August 14, 2026, disclosing the sale of 200,000 shares of common stock across three trading days between August 12 and August 14, 2026.
Patrick W. Fogarty, Vice President and CFO of Park Ohio Holdings Corp, filed a Form 4 on August 14, 2026, disclosing the sale of 12,000 shares of common stock on August 12, 2026, across eight separate transactions at prices ranging from $48.00 to $48.62 …
Brandon Moss, Chief Executive Officer and Director of Shoals Technologies Group, Inc. (NASDAQ:SHLS), filed a Form 4 on August 14, 2026, disclosing a tax-withholding transaction in Class A Common Stock dated August 13, 2026.
Ryan Fukushima, an officer at Tempus AI, Inc. (NASDAQ:TEM), filed a Statement of Changes in Beneficial Ownership on August 14, 2026, disclosing a transaction in Class A Common Stock dated August 12, 2026.
A statement of changes in beneficial ownership filed on August 14, 2026 reports that Katherine Motlagh, a director of Aeva Technologies, Inc., sold 2,500 shares of common stock on August 12, 2026.
A Form 4 filed with the SEC on August 14, 2026, discloses that Pablo J. Cagnoni, President and Global Head of R&D at Incyte Corp (NASDAQ:INCY), disposed of 10,803 shares of common stock on August 12, 2026, pursuant to a Rule 10b5-1 trading plan.
Emily M. Leproust, Chief Executive Officer and Director of Twist Bioscience Corp (NASDAQ:TWST), filed a Form 4 on August 14, 2026, reporting a stock option exercise and subsequent sale of common shares on August 12, 2026, conducted under a pre-established Rule 10b5-1 trading plan.
Tilman J. Fertitta, a director and 10% owner of Wynn Resorts Ltd (NASDAQ:WYNN), filed a Form 4 on August 14, 2026, disclosing the sale of three blocks of call option contracts on Wynn Resorts common stock, all transacted on August 12, 2026.
A Form 4 filed on August 14, 2026 discloses that Katryn Blake, a director of Twist Bioscience Corp (NASDAQ:TWST), sold 2,240 shares of common stock on August 12, 2026 to cover tax liability associated with the vesting of Restricted Stock Units.
Kevin Waters, Executive Vice President and CFO of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on August 14, 2026, disclosing the acquisition of restricted stock units and a stock option grant dated August 13, 2026.